BioVaxys Technology Corp. Closes First Tranche of Private Placement
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First...
Source: prnewswire.com
Vaxys Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Vaxys Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Vaxys Technology Today - Breaking & Trending Today
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the...
Source: prnewswire.com
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has received a Notice of Allowance...
Source: prnewswire.com
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.
VANCOUVER, BC, Feb. 21, 2024 /PRNewswire/ -- BioVaxys Technology Corp. is pleased to announce has completed the acquisition of the entire portfolio of discovery, preclinical and clinical...
Source: marketscreener.com
Annual Financial Statements Update for the Year Ended October 31, 2023
/PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that as a result of delays in the...
Source: prnewswire.com